OBJECTIVES: To evaluate the relationship between the presence and number of restricting symptoms and number of disabilities and subsequent admission to hospice at the end of life. DESIGN: Prospective cohort study. SETTING: Greater New Haven, Connecticut, from March 1998 to December 2014. PARTICIPANTS: Decedents from a cohort of 754 persons aged 70 and older (N = 562). MEASUREMENTS: Hospice admissions were identified primarily from Medicare claims, and 15 restricting symptoms and disability in 13 activities were assessed during monthly interviews. RESULTS: During their last year of life, 244 (43.4%) participants were admitted to hospice. The median duration of hospice was 12.5 days (interquartile range 4-43 days). Although the largest increases were observed in the last 2 months of life, the prevalence of restricting symptoms and mean number of restricting symptoms and disabilities in the preceding months were high and trending upward. During a specific month, the likelihood of hospice admission increased by 66% (adjusted hazard ratio (aHR) = 1.66, 95% confidence interval (CI) = 1.30-2.12) in the setting of any restricting symptoms, by 9% (aHR = 1.09, 95% CI = 1.05-1.12) for each additional restricting symptom, and by 10% (aHR = 1.10, 95% CI = 1.05-1.14) for each additional disability. Each additional month with any restricting symptoms increased the likelihood of hospice admission by 7% (aHR = 1.07, 95% CI = 1.01-1.13).
T he Medicare hospice benefit was established in 1982 to ensure that beneficiaries have access to high-quality palliative care in the last 6 months of life. Despite the tremendous growth in hospice over the past 30 years, concerns have been raised that it is often underused. [1] [2] [3] [4] [5] The median length of stay in hospice is only approximately 3 weeks, and approximately one-third of beneficiaries are referred to hospice in the last 7 days of life. 6 A possible explanation for this is that the eligibility requirement that beneficiaries have a life expectancy of 6 months or less for a defined set of specific conditions 6 that no longer includes debility 7 constrains access to hospice. As a second explanation, physicians may not weigh the burden of disability in their decision-making about hospice referral, despite evidence that functional status is one of the strongest predictors of mortality in older persons. [8] [9] [10] Because hospice is designed to ameliorate pain and other distressing symptoms, referral to hospice should be based, at least in part, on the burden of these symptoms, but the short duration of hospice, coupled with preliminary data from our group, suggest otherwise. Specifically, we found that a large proportion of older decedents have a high prevalence of restricting symptoms during the last year of life. 11 Moreover, the need for services at the end of life to assist with essential activities of daily living is at least as great for older persons dying from organ failure and frailty as for those dying from a more-traditional terminal conditions such as cancer, and the need is much greater for those dying from advanced dementia. 12 Nevertheless, the evidence indicates that hospice is underused for conditions other than cancer. 6 As highlighted in a recent Institute of Medicine report, 13 failing to refer or delaying referral of older persons to hospice at the end of life can place a high burden on caregivers 14 and result in suffering. 15 The objective of the current study was to evaluate the relationship between three clinically relevant exposures (presence and burden of restricting symptoms and burden of disability) and subsequent admission to hospice in the last year of life. We postulated that these associations would be weak or nonexistent. To test this hypothesis, we used high-quality data from a unique longitudinal study of older persons that includes monthly assessments of restricting symptoms and disability over more than 15 years and information on hospice admissions obtained from Medicare claims.
METHODS

Study Population
Participants were drawn from an ongoing longitudinal study of 754 community-living persons, aged 70 and older who were initially nondisabled in activities of daily living. 16, 17 Potential participants were members of a large health plan (managed care and fee for service). Individuals with significant cognitive impairment with no available proxy, 18 life expectancy of less than 12 months, plans to move out of the area, or inability to speak English were excluded. Only 4.6% of persons refused screening, and 75.2% of those eligible agreed to participate and were enrolled from March 1998 to October 1999. The Yale Human Investigation Committee approved the study, and all participants provided informed consent.
Analytical Sample
The current analysis focused on the last year of life for two reasons. First, Medicare coverage of hospice requires a physician to certify that life expectancy is 6 months or less if the terminal condition runs its normal course, and second, median survival in hospice was 2 weeks in our earlier study. 19 Of the 623 decedents through December 2014, 29 (4.7%) had dropped out of the study after a median follow-up of 27 months, 15 (2.4%) had been admitted to hospice more than 1 year before their death, 14 (2.2%) died suddenly and would not have been considered for hospice, 12 and three (0.5%) did not have sufficient information available on restricting symptoms and disability, leaving 562 participants in the analytical sample.
Data Collection
Comprehensive home-based assessments were completed at baseline and at 18-month intervals for up to 198 months (except for 126 months), and telephone interviews were completed monthly through December 2014, with a completion rate of 99%. When participants were unable to complete the monthly interviews, proxy data were obtained using a standard protocol. 18 A proxy completed 45.0% of the 6,629 monthly interviews in the current analysis. The accuracy of these proxy reports was moderate to substantial, 20 with a kappa of 0.66 for restricted activity 11 and intraclass correlation coefficient of 0.56 for burden of disability. Deaths were ascertained from the local obituaries or an informant. A certified nosologist coded cause of death using information from the death certificate. During the comprehensive assessments, data were collected on demographic characteristics; nine selfreported, physician-diagnosed chronic conditions; body mass index; cognitive status; 21 depressive symptoms; 22 and social support. 23 
Ascertainment of Restricting Symptoms
During the monthly interviews, the occurrence of restricting symptoms was ascertained using a standard protocol. 16 First, participants were asked two questions related to restricted activity: "Since we last talked, have you stayed in bed for at least half a day due to an illness, injury, or other problem?" and "Since we last talked, have you cut down on your usual activities due to an illness, injury, or other problem?" Second, if participants answered "yes" to either question, they were asked whether they had any of 24 prespecified symptoms or problems since the last interview. [24] [25] [26] [27] Third, immediately after each "yes" response to a specific symptom or problem, participants were asked, "Did this cause you to stay in bed for at least half a day or cut down on your usual activities?" As in prior studies, 11, 28 the current analysis focused on 15 restricting symptoms: fatigue; musculoskeletal pain; dyspnea; chest pain or tightness; nausea, vomiting, or diarrhea; depression; anxiety; arm or leg weakness; difficulty sleeping; dizziness or unsteadiness; difficulty with memory or thinking; swelling in feet or ankles; cold or influenza symptoms; poor or decreased vision; and urinary frequency, pain, or incontinence. The test-retest reliability of the protocol was high, with a kappa of 0.90 for restricted activity and 0.75 or greater for all restricting symptoms. 11 Data on restricted activity were missing for only 0.6% of the observations.
Assessment of Disability
Complete details regarding the assessment of disability are provided elsewhere. 17, 18, 29 During the monthly interviews, participants were asked, "At the present time, do you need help from another person to (complete the task)?" for each of four basic activities (bathing, dressing, walking, transferring), five instrumental activities (shopping, housework, meal preparation, taking medications, managing finances), and three mobility activities (walk one-quarter of a mile, climb flight of stairs, lift and carry 10 pounds). For these 12 activities, disability was defined as the need for personal assistance or unable to do the task. Participants were also asked about a fourth mobility activity, "Have you driven a car during the past month?" Participants who responded "No" were considered to be "disabled" in driving. 29 To address the small amount of missing data on disability (0.9% of observations), multiple imputation was used with 100 random draws per missing observation. 30 
Admission to Hospice
Hospice admissions through 2014 were identified primarily using Medicare claims. 31 For three participants, the admission was ascertained from a proxy informant and confirmed by review of medical records and death certificate.
Condition Leading to Death
Information from death certificates and the comprehensive assessments was used to classify the condition leading to death, according to the protocol provided in Table S1 . 12 
Statistical Analysis
The primary outcome was admission to hospice. Characteristics of the analytical sample were summarized according to hospice status using information from the comprehensive assessment that immediately preceded the study period (last year of life), except for age, living situation, and number of disabilities, which were ascertained from the telephone interview 12 months before death. The likelihood of hospice admission was evaluated for each of the conditions leading to death. The prevalence of restricting symptoms was calculated by dividing the number of participants with any restricting symptoms in a specific month by the total number of participants who completed an interview that month. The mean number (burden) of restricting symptoms (possible range 0-15) and disabilities (possible range 0-13) were also calculated each month.
We used Cox proportional hazards models to evaluate the associations between each of the three exposures and time to hospice admission during the last year of life. 32 Because all exposure variables were time varying, their value could change monthly. Participants were censored at the time of death or last completed interview if they dropped out of the study before their death (n = 5: n = 2, hospice; n = 3, no hospice). The association between each exposure and hospice admission was expressed as a hazard ratio (HR). For the presence of any restricting symptoms, the HR denotes the likelihood of hospice admission at month t (current month) based on the presence (vs absence) of any restricting symptoms at month t-1 (prior month). For the two other exposures, the HR denotes the relative risk of hospice admission at month t per one-unit increment in the number of restricting symptoms and disabilities at month t-1, respectively. These models were subsequently rerun with the following covariates: age, sex, race/ethnicity, education, living situation, number of chronic conditions, cognitive impairment, depression symptoms, low social support, and number of months since the comprehensive assessment. The overall fit of the final models was assessed using residual plots.
To enhance the clinical interpretation of our results, we calculated the adjusted absolute risk difference (ARD) for the presence of any restricting symptoms in month t-1, based on the cumulative probability of hospice admission over 12 months using the same time-varying Cox regression model, 31 and we estimated 95% confidence intervals (CI) using 100 bootstrapped samples. 33 The ARD denotes the difference in average probability of hospice admission between participants who had any restricting symptoms in month t-1 and those who did not. These calculations were based on marginal probabilities of the outcome, assuming that all participants were exposed and all participants were unexposed, respectively, while holding the covariates fixed.
To determine the association between the cumulative burden of restricting symptoms (during the exposure period) and subsequent hospice admission, we refit the Cox model, substituting the cumulative number of months with any restricting symptoms (for the presence of any restricting symptoms at month t-1) as a time-varying exposure whose value increased by 1 for each month a participant reported any restricting symptoms.
In a final set of analyses, the associations between the time-varying exposures and admission to hospice were evaluated according to the condition leading to death. All analyses were performed using SAS version 9.4 (SAS Institute, Inc., Cary, NC), and P < .05 (two-tailed) was used to indicate statistical significance.
RESULTS
Of the 562 decedents, 244 (43.4%) were admitted to hospice during their last year of life. Persons admitted to hospice were slightly older and more likely to have cognitive impairment than those who were not admitted to hospice ( Table 1 ). The most-common condition leading to death was frailty, followed by organ failure, advanced dementia, and cancer (Table S2 ). The likelihood of hospice admission was highest for cancer and advanced dementia, lowest for frailty and other conditions, and intermediate for organ failure. The mean AE standard deviation duration of hospice was 40.2 AE 69.3 days (median 12.5 days, interquartile range 4-43 days), with no significant differences according to the condition leading to death (P = .77). Figure 1 provides information about exposure to restricting symptoms and disability. The prevalence of restricting symptoms ( Figure 1A ) was relatively flat (0.20-0.24) until about 6 months before death, when it started increasing, reaching a peak of 0.56 one month before death. Similarly, the mean number of restricting symptoms ( Figure 1B ) was relatively flat (0.8-1.0) until approximately 6 months before death, when it started increasing, with the most-pronounced increase observed in the last 2 months of life. In contrast, the mean number of disabilities ( Figure 1C ) increased progressively throughout the last year of life, from 7.1 12 months before death to 10.7 1 month before death, with the greatest increases observed in the last 2 months of life. These patterns were generally similar for participants who were and were not admitted to hospice (Figure S1 ), although the values for each exposure were greater for the former than the latter, particularly in the month before death. Table 2 shows the associations between the three time-varying exposures and admission to hospice. In the setting of any restricting symptoms during a specific month, the likelihood of hospice admission within the following month increased by 66%, after adjustment for covariates. The corresponding increase per number of restricting symptoms was 9%. For each additional disability during a specific month, the likelihood of hospice admission within the following month increased by 10%. When evaluated as a time-varying cumulative exposure, each additional month with any restricting symptoms (up to month t-1) increased the likelihood of hospice admission at month t by 7% in unadjusted and adjusted analyses. The adjusted ARD for the presence of any restricting symptoms in a specific month, based on the cumulative probability of hospice admission over 12 months, was 15.3% (95% CI = 7.5-24.1%).
The associations between the time-varying exposures and admission to hospice, as denoted using adjusted hazard ratios, were weakest for advanced dementia but were generally consistent across the four other conditions leading to death, although several CIs spanned 1 ( Table 3) . The point estimates for the presence and number of restricting symptoms in a specific month were highest for cancer, whereas the point estimates for the number of disabilities in a specific month were highest for frailty and other conditions. For the cumulative number of months with any restricting symptoms, the association was statistically significant only for organ failure.
DISCUSSION
In this prospective longitudinal study of older persons, we found strong and consistent associations between three clinically relevant exposures and subsequent admission to hospice in the last year of life. During a specific month, the likelihood of hospice admission was 66% greater in the setting of any restricting symptoms, 9% greater for each additional restricting symptom, and 10% greater for each additional disability. Approximately four of every nine participants were admitted to hospice, although the duration of hospice was relatively short (mean 40 days, median 12.5 days). The timing of hospice admission may reflect the course of restricting symptoms and disability, which did not increase greatly in severity until the last 2 months of life.
Our results suggest that decisions about hospice admission at the end of life are based, at least in part, on the presence and burden of restricting symptoms and disability. We found that the likelihood of hospice admission increased by 7% for each additional month with any restricting symptoms. In absolute terms, the average probability of hospice admission was 15% higher in the last year of life for participants who had any restricting symptoms in a specific month than for those who did not.
Based on prior literature suggesting that hospice is often underused, [1] [2] [3] [4] [5] especially for conditions other than cancer, 6 we had expected to find weak to no associations between our three exposures and subsequent admission to hospice. Contrary to our expectations, we found that the associations were weak to nonexistent only for advanced dementia. Although these results should be interpreted cautiously given the limited power to detect statistically significant subgroup differences, estimating life expectancy for advanced dementia is difficult, 34 making referral to hospice particularly challenging.
Although the largest increases were observed in the last 2 months of life, the prevalence of restricting symptoms and mean number of restricting symptoms and disabilities in the preceding months were high and trending upward. Whether earlier referral to hospice would have alleviated the burden of distressing symptoms and disability is uncertain. In an earlier study, 28 we found that the number of restricting symptoms at the end of life decreased significantly after the start of hospice.
Prior reports have raised concerns that the Medicare hospice benefit may not adequately address the care needs Characteristics were ascertained during the comprehensive assessment that preceded the last year of life except for age, living situation, and number of disabilities, which were ascertained in Month 1 of the last year of life.
a For statistical comparisons between decedents who were and were not admitted to hospice in their last year of life, the chi-square test was used for dichotomous variables and living situation, and the t-test was used for continuous variables. of persons whose illnesses result in a prolonged period of severe disability. 1, 3, 4 In the setting of distressing symptoms and progressive disability, an alternative to hospice at the end of life is palliative care. Prior studies that have shown beneficial effects of palliative care on symptom burden, although the benefit on functional outcomes is less certain. 35, 36 The absence of information on receipt of palliative care before the start of hospice is a limitation of the current study.
Several other limitations warrant comment. First, because participants were members of a single health plan in a small urban area in Connecticut, our results may not be generalizable to older persons in other settings or states, although the demographic characteristics of our cohort reflect those of older persons in New Haven County, Connecticut, which are similar to the characteristics of the U.S. population as a whole, with the exception of race and ethnicity. 37 Also, use of hospice in the current study (43.4% of deaths) was comparable with national estimates (44.6% of deaths). 38 Second, the use of information from death certificates is an imperfect strategy for classifying conditions leading to death. Previous research has shown that the concordance between coding of death certificates by a nosologist and an adjudicated cause of death is high for cancer and moderate for congestive heart failure and chronic lung disease but only fair for dementia, 39 largely because of underreporting of dementia on death certificates. We used data from cognitive testing in addition to coding by a nosologist to classify advanced dementia as a condition leading to death. Third, disease-specific information was not available on severity of illness. Restricting symptoms and disability are common manifestations of severity of illness in older persons. Fourth, proxies completed a substantial minority of the monthly interviews. The relatively high concordance between proxy and participant reports for restricting symptoms and disability diminishes this limitation, which is inherent in end-of-life studies.
Our study included monthly assessments of restricting symptoms and disability over an extended period of time, with little missing data and few losses to follow-up for reasons other than death. To our knowledge, comparable data are available in no other study. Additional strengths of the study include the high participation rate and use of Medicare claims to ascertain hospice admissions. Our focus on symptoms leading to restricted activity and disability in basic, instrumental, and mobility activities enhances the clinical relevance of our findings because Results reflect the marginal (average) effect of each exposure at month t-1 on hospice admission at month t. proper management of these symptoms and disabilities may substantially improve quality of life while reducing caregiver burden.
In summary, hospice services appear to be suitably targeted to older persons with the greatest needs at the end of life, although the short duration of hospice suggests that additional strategies are needed to better address the high burden of distressing symptoms and disability at the end of life.
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